{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/fortrea-clinical-pharmacology-services#webpage",
"url": "https://www.fortrea.com/insights/fortrea-clinical-pharmacology-services",
"name": "Fortrea clinical pharmacology services",
"description": "Fortrea Clinical Pharmacology Services provides integrated scientific, operational, and clinical expertise to support drug development from preclinical assessment through clinical execution and commercialization. Combining clinical pharmacology units, study design and monitoring, project management, biometrics, bioanalysis, biomarkers, pharmacokinetics, and PK modeling and simulation, Fortrea delivers comprehensive solutions across critical development milestones. The organization offers extensive experience in first-in-human (FIH) studies, human absorption, metabolism and excretion (hAME) studies, radiolabeled research, and specialized renal and hepatic impairment studies, helping sponsors generate the evidence needed for informed regulatory and development decisions. With access to more than 300 research beds across the U.S. and UK, over 83,000 healthy volunteers, cGMP Phase I manufacturing capabilities, and a broad network of clinical pharmacology facilities, Fortrea supports the efficient execution of complex clinical programs. Backed by industry-leading expertise in radiolabeled hAME studies, volunteer and patient recruitment, and integrated clinical pharmacology services, Fortrea helps sponsors accelerate timelines, optimize study quality, enhance patient safety, and advance innovative therapies with confidence."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Fortrea clinical pharmacology services",
"item": "https://www.fortrea.com/insights/fortrea-clinical-pharmacology-services"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/fortrea-clinical-pharmacology-services#infosheet",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/fortrea-clinical-pharmacology-services#webpage"
},
"headline": "Integrated Clinical Pharmacology Services for FIH, hAME and Impairment Studies | Fortrea Info Sheet",
"description": "Fortrea Clinical Pharmacology Services provides integrated scientific, operational, and clinical expertise to support drug development from preclinical assessment through clinical execution and commercialization. Combining clinical pharmacology units, study design and monitoring, project management, biometrics, bioanalysis, biomarkers, pharmacokinetics, and PK modeling and simulation, Fortrea delivers comprehensive solutions across critical development milestones. The organization offers extensive experience in first-in-human (FIH) studies, human absorption, metabolism and excretion (hAME) studies, radiolabeled research, and specialized renal and hepatic impairment studies, helping sponsors generate the evidence needed for informed regulatory and development decisions. With access to more than 300 research beds across the U.S. and UK, over 83,000 healthy volunteers, cGMP Phase I manufacturing capabilities, and a broad network of clinical pharmacology facilities, Fortrea supports the efficient execution of complex clinical programs. Backed by industry-leading expertise in radiolabeled hAME studies, volunteer and patient recruitment, and integrated clinical pharmacology services, Fortrea helps sponsors accelerate timelines, optimize study quality, enhance patient safety, and advance innovative therapies with confidence.",
"genre": "Info Sheet",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2026-07-24",
"dateModified": "2026-07-24",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2026-07/fortrea-pharmacology.pdf",
"encodingFormat": "application/pdf"
}
}
]
}